By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Appoints Mark Strobeck, Ph.D. To Executive Vice President And Chief Operating Officer 10/5/2015 6:26:25 AM
Egalet Provides Commercial Update On SPRIX Nasal Spray And OXAYDO Along With Pipeline Review At Investor Day 9/29/2015 6:40:35 AM
Egalet Announces Investor Day 9/15/2015 8:46:24 AM
Egalet Announces Scientific Data At PAINWeek 2015 Meeting Supports Analgesic Efficacy Of SPRIX Nasal Spray Versus Commonly Prescribed Oral Combination Opioids In Treatment Of Moderate To Severe Short-Term Pain 9/10/2015 6:46:17 AM
Egalet Announces Commercial Launch Of OXAYDO, The First And Only Immediate-Release Oxycodone Designed To Discourage Intranasal Abuse, And Launch Of IMPACT-Rx, A Patient Access Initiative 9/9/2015 6:07:54 AM
Egalet Announces Scientific Presentations At PainWeek 2015 Meeting 9/1/2015 6:57:21 AM
Egalet Reports Second Quarter 2015 Financial Results And Provides Business Update 8/6/2015 10:37:14 AM
Egalet Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/3/2015 6:49:52 AM
Egalet Announces Pricing Of Public Offering Of Common Stock 7/29/2015 10:24:44 AM
Egalet Announces Proposed Public Offering Of Common Stock 7/28/2015 12:38:08 PM